www.fdanews.com/articles/87649-ge-trials-first-pet-imaging-agent-to-track-blood-vessel-growth-in-cancer
GE TRIALS FIRST PET IMAGING AGENT TO TRACK BLOOD VESSEL GROWTH IN CANCER
June 16, 2006
GE Healthcare, a division of the General Electric Company has begun a clinical study of a new chemical for use in positron emission tomography (PET) imaging that could be used to monitor angiogenesis, the formation of new blood vessels in tumours.
Medical Technology Business Europe (http://mtbeurope.info/news/2006/606014.htm)